Regenerative Medical Tech RMTG

$0.04 0.00 (—)

Valuation

Market cap: —
Revenue TTM: $0
Net income TTM: $0
PE ratio: —
Forward PE: —
Profit margin: 0.00%
Debt to equity: —

Trading

Volume: 5,000
Avg volume: 60,210
Day's range: $0.04 – $0.04
Shares out: —
Stochastic %K: 37%
Beta: —
Analysts: Strong Buy
Price target: —

Price

Company profile

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. Further, it provides solutions from clinical research with the manufacturing and commercialization of viable cell therapy and immune support related products. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.

Industry: Biotechnology
Sector: Healthcare
Phone: 800 956 3935
Website: https://regenmedtechgroup.com
Address: 433 Plaza Real, Suite 275, Boca Raton, United States

Latest news

No headlines yet.

Stocktwits

Manamal Oct 13, 5:04 PM

$RMTG Not sure where your seeing teens soon, Market cap only $635,000, only 15 million shares outstanding out of 400,000 shares. Granted the float is only 11,234,096 which is awesome. However, the company continues to face financial challenges, including a widening stockholders' deficit and high liabilities.

1 replies

DeProfundis Sep 4, 7:12 PM

$RMTG $4M quarterly revenue, $1.1M market cap, you do the math :)

3 replies

RollingPins Aug 31, 8:33 PM

$RMTG ready for our push into the teens here

0 replies

swedishfish Aug 25, 2:12 PM

$RMTG $39 million shareholders defecit with ~$1.3million in cash. $1.2 million in promisory notes currently in default. Solid revs the past 2 quarters but how does everyone anticipate they get out of this mess (more like crisis) without massive capital restructure and dilution?

3 replies

Slickaj115 Aug 24, 4:53 PM

$RMTG unmmm how about some……volume?

0 replies

flychicken1991 Aug 24, 11:10 AM

$RMTG Positive (64%): shares could receive modest upward support because the launch creates a possible new international revenue channel, although the absence of disclosed customers, orders, pricing, or expected sales limits the basis for a larger revaluation. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/604951da5951610d/rmtg-rmtg-s-cellgenic-division-launches-natural-killer-nk-cell-product-l?utm_source=stocktwits&utm_medium=story_url

0 replies

ZRadly Aug 22, 8:02 PM

$RMTG Where we heading this week?😉

0 replies

RollingPins Aug 21, 8:03 PM

$RMTG nice double digit close to end the week here. Let’s push this into the teens next week.

0 replies